Product Image

Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst

Coromega
4.8
★ ★ ★ ★ ★
(360 ratings)
EPA (Eicosapentaenoic Acid) 625 mg
Fish Oil 2000 mg
Omega-3 1200 mg
DHA 425 mg
Product Image
Score75
A convenient high-dose squeeze with named fish sources and vitamin D, but incomplete quality details and middling value.
How scoring works
Quantity:60 Squeeze Shot(s) • (30 servings)
Goals:
Anti-Inflammatory Support
Cardiovascular Support
Heart Health
Skin Health
Joint Health
Vision Support
Metabolism Boost

Score 75

A convenient high-dose squeeze with named fish sources and vitamin D, but incomplete quality details and middling value.
How scoring works

Also available as

2 options
90 servings DHA 850 mg, EPA (Eicosapentaenoic Acid) 1250 mg +2 more • 90 Squeeze Shot(s) • 45 servings $48.96 ($1.08 per serving) Coconut Bliss DHA 850 mg, EPA (Eicosapentaenoic Acid) 1250 mg +2 more • 90 Squeeze Shot(s) • 45 servings $48.96 ($1.08 per serving)
$30.05($1.00 per serving)
iHerb
$ 30.05
Report prices

Analysis

A serving provides 1,200 mg omega-3s, including 625 mg EPA and 425 mg DHA, plus 13 mcg vitamin D3. The balance supports heart, skin, joint, and inflammatory goals, although the listed title amount does not match the 2,000 mg fish-oil amount shown in the ingredients.

Anchovy, mackerel, and sardine sources are identified, which is more informative than a generic fish-oil label. Molecular form, independent purity results, antioxidant protection, and the complete citrus flavor system are not included in the supplied data.

Individual squeeze shots may help people who dislike swallowing softgels. The convenience format carries only moderate serving value and creates more packaging than a bottle of capsules.

Who is it for
  • Adults who dislike swallowing fish-oil capsules
  • People seeking a flavored, portable omega-3 dose
Best for
  • Squeeze-shot convenience
  • Substantial EPA and DHA intake

Pros

  • 1,200 mg total omega-3s per serving
  • Anchovy, mackerel, and sardine are named
  • Includes vitamin D3

Cons

  • Molecular form and purity testing are not stated
  • Complete flavor ingredients are absent
  • Convenience format has moderate serving value

Warnings

  • Avoid with an allergy to anchovy, mackerel, sardine, or other fish
  • EPA and DHA can add to anticoagulant or antiplatelet effects
  • Account for the added vitamin D when combining it with other vitamin D supplements

Nutrient quality

86 Highest impact

A standard effective EPA plus DHA amount and named small-fish sources provide good formula quality. Moderate concentration and missing form, oxidation, and purity safeguards limit refinement.

Ingredient transparency

71 High impact

Core fatty-acid quantities are visible and no proprietary blend hides the formula. Malformed entries, missing full directions, and undisclosed excipients substantially reduce clarity.

Customer satisfaction

69 High impact

The supplied average rating is very strong and the rating volume is moderate. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money

72 High impact

The formula offers fair value for its cost. It remains moderately competitive but does not clearly lead the category.

Report analysis

Goals

Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitA Strength of SupportA- CoverageA+ Formula Quality
Vitamin D · 13 mcgFish Oil · 2000 mg

EPA and DHA directly influence inflammatory signaling and support production of inflammation-resolving mediators. Vitamin D adds a complementary immune-regulating nutrient to the substantial omega-3 core.

The 1,050 mg combined EPA and DHA amount is useful and clearly disclosed. The focused liquid formula provides good depth without relying on a long list of minor actives.

Study evidence
Vitamin D Supportive 101 studies
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A+ Goal FitA Strength of SupportB CoverageA+ Formula Quality
Vitamin D · 13 mcgFish Oil · 2000 mg

The serving supplies 625 mg EPA and 425 mg DHA, directly supporting triglyceride management and vascular health. Fish oil has strong human evidence for cardiovascular risk markers.

The fully disclosed EPA and DHA amounts provide strong depth in a focused omega-3 formula. The chemical form and independent oxidation testing are not provided, leaving some quality uncertainty.

Study evidence
Fish Oil Supportive 185 studies
Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 625 mgVitamin D · 13 mcg

EPA and DHA directly support triglyceride management and other cardiovascular functions. The disclosed balance provides meaningful omega-3 depth for general heart support.

The serving lists 625 mg EPA and 425 mg DHA separately, which makes the active amount easy to assess. Molecular form, oxidation control, and independent contaminant testing are not disclosed.

Study evidence
Skin Health
Skin Health
Impact
Highest effect
A- Goal FitA- Strength of SupportC+ CoverageA Formula Quality
Omega-3 · 1200 mg

EPA and DHA may support skin-barrier lipids and inflammatory balance. The serving lists 625 mg EPA and 425 mg DHA within 1,200 mg total omega-3 fatty acids.

Separate fatty-acid amounts are transparent, but molecular form, oxidation protection, and independent contaminant testing are not disclosed. The focused oil provides useful depth without collagen or antioxidant breadth.

Study evidence
Omega-3 Supportive 35 studies
Joint Health
Joint Health
Impact
Highest effect
A- Goal FitA Strength of SupportC- CoverageA Formula Quality
Omega-3 · 1200 mg

EPA and DHA provide meaningful anti-inflammatory support that may help joint comfort. The formula is focused and does not supply cartilage building blocks or direct lubrication support.

The EPA, DHA, total omega-3, oil amount, and fish sources are clearly disclosed. Fish-derived oil can trigger an allergic reaction in people with fish allergy, and higher-dose use warrants attention with anticoagulant or antiplatelet therapy.

Study evidence
Omega-3 Supportive 40 studies
Vitamin D Supportive 111 studies
Vision Support
Vision Support
Impact
High effect
B Goal FitB Strength of SupportC+ CoverageB+ Formula Quality
EPA (Eicosapentaenoic Acid) · 625 mg

The disclosed EPA and DHA amounts provide meaningful structural support for retinal membranes and may also support ocular surface comfort. The formula is focused, but it does not provide the carotenoids or antioxidant nutrients used for broader vision support.

Clear fatty-acid amounts make the serving easy to assess. The label does not identify the oil's molecular form, oxidation protection, or contaminant testing, which limits confidence in quality.

Study evidence

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Saturated Fat
0 Gram(s)
Cholesterol
10 mg
Vitamin D3
13 mcg
Fish Oil
2000 mg
Omega-3 Fatty Acids
1200 mg
Eicosapentaenoic Acid
625 mg
Docosahexaenoic Acid
425 mg
Stevia Leaf Extract
10 mg
Gluten Free Adults 18–50 Dairy Free Children 4+
Report overview
EPA (Eicosapentaenoic Acid) · 625 mg OverallScore50
D- Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD+ Value

The serving provides 625 mg EPA, and epa is higher than dha but narrowly misses the preferred ratio. EPA makes up a moderate share of the fish oil, but the molecular form and contaminant-testing status are not disclosed. EPA cost efficiency is moderate, while no oil-protection antioxidant is listed.

View ingredientView products
Fish Oil · 2000 mg OverallScore43
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyD+ Value

Anchovy, mackerel, and sardine provide clearly identified small-fish sources. EPA and DHA are individually disclosed at a standard effective combined dose, although they make up only a moderate share of the total fish oil. Missing molecular-form, purification, independent-testing, and antioxidant details limit quality assurance despite average active-omega-3 value.

View ingredientView products
Omega-3 · 1200 mg OverallScore42
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyD+ Value

EPA and DHA are clearly disclosed from small-fish oil, making the active serving easy to assess. Their combined amount is just over half of the fish oil, while the molecular form, antioxidant protection, and independent purity testing are not shown. Cost per active gram falls in a moderate premium range.

View ingredientView products
Loading alternative details
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
A stronger supplied quality profile than Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst is supported by a highly concentrated 1,100 mg triglyceride omega-3 serving with clear EPA and DHA amounts. Molecular distillation adds purity assurance, though fish species, antioxidant protection, and independent testing are not stated.
86 Performance

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
A stronger supplied quality profile than Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst is supported by a substantial serving with EPA and DHA stated separately. The ethyl-ester form is less readily absorbed than triglyceride oil, and oxidation protection plus independent testing are not supplied.
85 Performance

Wild Alaskan Fish Oil Peak EPA

Wiley's Finest
A stronger supplied quality profile than Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst is supported by a concentrated EPA-heavy serving with individual fatty-acid amounts clearly stated. Molecular form, oxidation protection, purification, and independent testing remain unspecified.
79 Budget

Fish Oil 1000 mg

Mason Natural
Lower recurring cost is the clearest advantage over Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst, while the formula provides clearly disclosed EPA and DHA in a basic 1,000 mg fish-oil softgel. The active omega-fat amount is low, and source, molecular form, oxidation protection, and purity testing are not supplied.
82 Budget

Omega 3 Fish Oil Concentrate

Solgar
Lower recurring cost is the clearest advantage over Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst, while the formula provides a modest, clearly disclosed EPA and DHA serving for routine use. Low concentration plus missing molecular-form, source, oxidation, and purity details limit quality confidence.
69 Budget

Kid's Chewable DHA 100 mg Bursting Orange Flavor!

Carlson
Lower recurring cost is the clearest advantage over Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst, while the formula provides triglyceride fish oil and vitamin E in a child-friendly chewable with 100 mg DHA. The active omega-3 amount and oil concentration are low, and independent purity testing is not supplied.
84 Value

Omega-3 Fish Oil 1250 mg

SR Sports Research
Lower recurring cost paired with a highly concentrated EPA-led fish-oil serving in one softgel creates a useful value trade-off versus Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst. Molecular form, purification, antioxidant protection, fish species, and independent testing are not supplied.
84 Value

Fish Oil 1400 mg

Nature's Bounty
Lower recurring cost paired with a meaningful EPA-led amount with strong oil concentration creates a useful value trade-off versus Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst. The ethyl-ester form is less readily absorbed, and fish source, antioxidant protection, and independent testing are not stated.
82 Value

Triple Strength Omega-3

InnovixLabs
Lower recurring cost paired with a concentrated mix of EPA, DHA, DPA, and other omega-3 fats in a long supply creates a useful value trade-off versus Max High Concentrate Omega-3 Fish Oil 2400 mg Citrus Burst. Molecular form, purification, fish species, antioxidant protection, and independent testing are missing, and one label row is malformed.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  5. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  7. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  8. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation.
    Furuhjelm C; Warstedt K; Fagerås M; Fälth-Magnusson K; Larsson J; Fredriksson M; Duchén K · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2011
    Randomized trial145 participantsSkin Health forOmega-3
  9. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study.
    Søyland E; Funk J; Rajka G; Sandberg M; Thune P; Rustad L; Helland S; Middelfart K; Odu S; Falk ES · The British journal of dermatology · 1994
    Randomized trial145 participantsSkin Health forOmega-3
  10. Prenatal Omega-3 Supplementation and Eczema Risk among Offspring at Age 36 Months.
    Berman D; Clinton C; Limb R; Somers EC; Romero V; Mozurkewich E · Insights in allergy, asthma & bronchitis · 2020
    Randomized trial84 participantsSkin Health forOmega-3
  11. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  12. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  13. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Song GG · Archives of medical research · 2013
    Meta-analysis10 studies pooledJoint Health forOmega-3
  14. Dietary Long-Chain n-3 Fatty Acid Intake and Arthritis Risk in the Women's Health Initiative.
    Krok-Schoen JL; Brasky TM; Hunt RP; Rohan TE; Baker TA; Li W; Carbone L; Mackey RH; Snetselaar L; Lustberg MB; Neuhouser ML · Journal of the Academy of Nutrition and Dietetics · 2019
    Cohort study80,551 participantsJoint Health forOmega-3
  15. Vitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study.
    Zhou A; Hyppönen E · International journal of epidemiology · 2023
    Observational study294,970 participantsAnti-Inflammatory Support forVitamin D
  16. Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial.
    El Amrousy D; El Ashry H; Hodeib H; Hassan S · Journal of clinical gastroenterology · 2021
    Randomized trial120 participantsAnti-Inflammatory Support forVitamin D
  17. Vitamin D supplementation reduces infection rate and promotes wound healing in patients with diabetic foot ulcers.
    Gao YQ; Gao YH; Xing JH · World journal of diabetes · 2025
    Randomized trial120 participantsAnti-Inflammatory Support forVitamin D
  18. Associations of C-reactive Protein with 25-hydroxyvitamin D in 24 Specific Diseases: A Cross-sectional Study from NHANES.
    Yang F; Sun M; Sun C; Li J; Yang X; Bi C; Wang M; Pu L; Wang J; Wang C; Xie M; Yao Y; Jin L · Scientific reports · 2020
    Cross-sectional study9,809 participantsAnti-Inflammatory Support forVitamin D
  19. Combined effects of vitamin D deficiency and systemic inflammation on all-cause mortality and cause-specific mortality in older adults.
    Zhang C; Cui J; Li S; Shen J; Luo X; Yao Y; Shi H · BMC geriatrics · 2024
    Cohort study3,072 participantsAnti-Inflammatory Support forVitamin D
  20. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  21. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  22. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  23. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  24. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  25. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  26. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  27. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  28. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  29. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  30. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  31. Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis.
    Wang X; Cicuttini F; Jin X; Wluka AE; Han W; Zhu Z; Blizzard L; Antony B; Winzenberg T; Jones G; Ding C · Osteoarthritis and cartilage · 2018
    Randomized trial413 participantsJoint Health forVitamin D
  32. Vitamin D Deficiency Leads to Poorer Health Outcomes and Greater Length of Stay After Total Knee Arthroplasty and Supplementation Improves Outcomes: A Systematic Review and Meta-Analysis.
    Vivek K; Kamal R; Perera E; Gupte CM · JBJS reviews · 2024
    Meta-analysis146,054 participants10 studies pooledJoint Health forVitamin D
  33. Does vitamin D improve symptomatic and structural outcomes in knee osteoarthritis? A systematic review and meta-analysis.
    Zhao ZX; He Y; Peng LH; Luo X; Liu M; He CS; Chen J · Aging clinical and experimental research · 2021
    Meta-analysis1,599 participants6 studies pooledJoint Health forVitamin D
  34. Baseline 25-hydroxyvitamin D levels predict the effects of vitamin D supplementation on joint symptoms and cartilage loss in patients with knee osteoarthritis.
    Wang T; Zheng S; Jin X; Cen H; Zhu Z; Han W; Wluka A; Cicuttini F; Cao P; Ding C · Rheumatology advances in practice · 2025
    Randomized trial413 participantsJoint Health forVitamin D
  35. The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis.
    Yang W; Sun C; He SQ; Chen JY; Wang Y; Zhuo Q · Journal of general internal medicine · 2021
    Meta-analysis11,890 participants28 studies pooledJoint Health forVitamin D
  36. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  37. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  38. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  39. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  40. Three Doses of Vitamin D and Cognitive Outcomes in Older Women: A Double-Blind Randomized Controlled Trial.
    Castle M; Fiedler N; Pop LC; Schneider SJ; Schlussel Y; Sukumar D; Hao L; Shapses SA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Randomized trialMental Focus forVitamin D
  41. Vitamin D and executive function: a preliminary report.
    Hansen AL; Dahl L; Bakke L; Thayer JF · Perceptual and motor skills · 2012
    Cross-sectional study25 participantsMental Focus forVitamin D
  42. Effects of Vitamin D Supplementation on Cognitive Function in Older Adults: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Methodology-Assessed Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Behrouzi R; Shahinfar H; Jazayeri S · Nutrition reviews · 2026
    Meta-analysis9 studies pooledMental Focus forVitamin D
  43. Maternal vitamin D concentrations are associated with faster childhood reaction time and response speed, but not with motor fluency and flexibility, at the age of 5-6 years: the Amsterdam Born Children and their Development (ABCD) Study.
    Brouwer-Brolsma EM; Vrijkotte TGM; Feskens EJM · The British journal of nutrition · 2019
    Cohort study1,854 participantsMental Focus forVitamin D
  44. Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study.
    Granic A; Hill TR; Kirkwood TB; Davies K; Collerton J; Martin-Ruiz C; von Zglinicki T; Saxby BK; Wesnes KA; Collerton D; Mathers JC; Jagger C · European journal of neurology · 2015
    Cohort study775 participantsMental Focus forVitamin D
  45. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  46. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  47. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  48. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  49. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  50. Effects of vitamin D supplementation on insulin resistance and lipid metabolic profiles in women with gestational diabetes mellitus: A randomized controlled trial.
    Duan Y; Zhang S; Ma X; Li L; Jia K · African journal of reproductive health · 2026
    Randomized trial120 participantsMetabolism Boost forVitamin D
  51. Vitamin D3 improves glucose metabolism and attenuates inflammation in prediabetic human and mice.
    Zhang Y; Ni P; Miao Y; Chen H; Tang L; Song H; Li W; Li X · The Journal of nutritional biochemistry · 2024
    Randomized trialMetabolism Boost forVitamin D
  52. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.
    Mitri J; Dawson-Hughes B; Hu FB; Pittas AG · The American journal of clinical nutrition · 2011
    Randomized trial92 participantsMetabolism Boost forVitamin D
  53. The Effects of Vitamin D Supplementation on Glycemic Control, Lipid Profiles and C-Reactive Protein Among Patients with Cardiovascular Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ostadmohammadi V; Milajerdi A; Ghayour-Mobarhan M; Ferns G; Taghizadeh M; Badehnoosh B; Mirzaei H; Asemi Z · Current pharmaceutical design · 2020
    Meta-analysis630 participants8 studies pooledMetabolism Boost forVitamin D
  54. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis.
    Mirhosseini N; Vatanparast H; Mazidi M; Kimball SM · The Journal of clinical endocrinology and metabolism · 2017
    Meta-analysis1,528 participants24 studies pooledMetabolism Boost forVitamin D
  55. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  56. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  57. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  58. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  59. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  60. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsVision Support forEPA (Eicosapentaenoic Acid)
  61. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledVision Support forEPA (Eicosapentaenoic Acid)